Logotype for Insulet Corporation

Insulet (PODD) investor relations material

Insulet Baird Global Healthcare Conference 2025 summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Insulet Corporation
Baird Global Healthcare Conference 2025 summary9 Sep, 2025

Key business and financial updates

  • Achieved over $2 billion in 2024 revenue, serving more than 500,000 global customers, with Omnipod 5 as the flagship product used by over 350,000 people in 25 markets.

  • Q2 2025 revenue reached $649.1M, up 31.3% year over year; gross margin at 69.7%, and adjusted operating margin at 17.8%, both showing significant improvement.

  • Raised full-year 2025 guidance to 24–27% total revenue growth and 17–17.5% adjusted operating margin.

  • Redeemed $380 million in convertible notes and refinanced Term Loan B, strengthening the balance sheet.

  • International growth remains strong, with major markets like UK, Germany, France, and the Netherlands continuing to expand.

Strategic initiatives and innovation

  • Launched iOS Omnipod 5 app for iPhone, integrated with Dexcom G7 and FreeStyle Libre 2+ sensors in select markets.

  • Building a robust data ecosystem with Omnipod 5, enabling real-world evidence collection and insights for patients and physicians.

  • Accelerating innovation with parallel development, faster sensor integrations, and ongoing pivotal studies for next-gen hybrid and fully closed-loop systems.

  • Investing over $1 billion in advanced automation and manufacturing, supporting product differentiation and scalability.

  • Expanding commercial execution and market shaping, especially in underpenetrated Type 2 and international Type 1 diabetes markets.

Product innovation and market leadership

  • Omnipod 5 is the first FDA-cleared AID system for both type 1 and type 2 diabetes in the U.S.

  • Holds #1 position in U.S. for requested and prescribed AID system and new customer starts since 2023.

  • Unique tubeless, disposable, waterproof form factor and ease of use are key competitive advantages, protected by patents and trade secrets.

  • Available in over 47,000 U.S. pharmacies and covered by Medicare Part D.

  • Demonstrated significant improvements in glycemic results and reduced diabetes distress in clinical studies.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Insulet earnings date

Logotype for Insulet Corporation
Q3 20256 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Insulet earnings date

Logotype for Insulet Corporation
Q3 20256 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Insulet Corporation is a medical device company that develops and manufactures tubeless insulin pump systems for people with diabetes. Its flagship product is a wearable device that delivers continuous subcutaneous insulin infusion. The company markets its technology directly and through partnerships with healthcare providers. Insulet Corporation is headquartered in Acton, Massachusetts, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage